Eli Lilly is investing $6.5 billion to build a major pharmaceutical manufacturing campus in Houston, expected to produce pill-form GLP-1 weight-loss drugs and other small-molecule medicines. The 236-acre facility will create approximately 600 permanent jobs and 4,000 construction positions, while the company is also funding $15 million in workforce development at San Jacinto College. Construction begins now with completion targeted for November 2027.